bacillus Calmette-Guérin (BCG)
Partial interferon gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette Guérin infection and a sibling with clinical tuberculosis
8
Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin
5
Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guérin
9
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
5
Avoiding COVID-19 Complications with Diabetic Patients Could Be Achieved by Multi-Dose Bacillus Calmette–Guérin Vaccine: A Case Study of Beta Cells Regeneration by Serendipity
24
Complications of Intravesical Bacillus Calmette Guérin
5
Disseminated Bacillus Calmette Guérin (BCG) infections in infants with immunodeficiency
5
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
6
Benchmarking health system performance across districts in Zambia: a systematic analysis of levels and trends in key maternal and child health interventions from 1990 to 2010
14
Distribution and determinants of young child feeding practices in the East African region: demographic health survey data analysis from 2008-2011
14
Chakraborty
5
Efficient Activation of Human T Cells of Both CD4 and CD8 Subsets by Urease-Deficient Recombinant Mycobacterium bovis BCG That Produced a Heat Shock Protein 70-M. tuberculosis-Derived Major Membrane Protein II Fusion Protein
11
Integration of maternal postpartum services in maternal and child health services in Kaya health district (Burkina Faso): an intervention time trend analysis
13
Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas
8
The 2nd meeting of the Campania Society of Oncology Immunotherapy (SCITO): focus on hepatocellular carcinoma, kidney and bladder cancer
6
Benchmarking health system performance across states in Nigeria: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 2000–2013
16
Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation
11
Delivery strategies to enhance oral vaccination against enteric infections
18
High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: a prospective cohort study
11
Diagnostic value of the interferon γ release assay for tuberculosis infection in patients with Behçet’s disease
8